Thierry Alcindor

12PUBLICATIONS
106CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 06, 2026
Patterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency.

|Apr 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

|Mar 12, 2026
In search of the best perioperative treatment for gastroesophageal cancer: is there a role for antiangiogenesis?

Thierry Alcindor

|Oct 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial.

Ravin Ratan, Bernd Kasper, Thierry Alcindor

|Oct 04, 2024
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.

Nick Pavlakis, Kohei Shitara, Katrin Sjoquist

|Jul 12, 2024
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib.

Hans Gelderblom, Albiruni A Razak, Matthew H Taylor

Pageof 2

Frequent Collaborators

4 joint publications

Andrew J Wagner

3 joint publications

Mrinal M Gounder

3 joint publications

Richard F Riedel

2 joint publications

Albiruni Abdul Razak